Diving and Hyperbaric Medicine is a premier journal published by the SOUTH PACIFIC UNDERWATER MEDICAL SOCIETY that focuses on the critical intersection of diving medicine and hyperbaric physiology. With an ISSN of 1833-3516, this journal has become an essential resource for researchers, healthcare professionals, and students interested in the fields of public health, environmental health, and occupational health, as reflected in its Q3 ranking in the 2023 category quartiles. Since its inception in 2006, it has consistently provided high-quality peer-reviewed articles that address the latest clinical practices, research findings, and technological advancements in underwater medicine. Supporting a broad readership with its commitment to knowledge dissemination, Diving and Hyperbaric Medicine serves as a valuable platform for sharing innovations and challenges faced in hyperbaric treatments and diving safety protocols. Although not currently open access, it remains a recognized journal with significant contributions to the field, housed in Australia, at C/O AUSTRALIAN & NEW ZEALAND COLL ANAESTHETISTS, 630 ST KILDA RD, MELBOURNE VIC 3004, AUSTRALIA. Join the academic discourse and explore insights vital for improving diving safety and health outcomes in this dynamic domain.

JOURNAL OF EXPERIMENTAL MEDICINE, published by Rockefeller University Press, is a renowned peer-reviewed journal dedicated to advancing the field of experimental medicine since its inception in 1896. With an impressive impact factor and categorized in the Q1 quartile for Immunology, Immunology and Allergy, and Miscellaneous Medicine, this journal stands at the forefront of medical research and innovation. It provides a prestigious platform for scholars and practitioners to disseminate groundbreaking findings that drive the understanding of disease mechanisms and therapeutic strategies. While the journal is not open access, it maintains high visibility and engagement within the scientific community, fostering collaboration among researchers, professionals, and students alike. The journal's consistent ranking in the top percentiles of Scopus illustrates its significant impact and commitment to excellence in medical research.

Journal of Ginseng Research is a leading peer-reviewed publication dedicated to advancing the scientific knowledge and understanding of ginseng and its myriad applications in health and wellness. Published by KOREAN SOC GINSENG and located in the Netherlands, this open-access journal has been a pivotal resource for researchers, professionals, and students since its inception. With an impactful H-index and prestigious rankings in various categories, including Q1 in Biochemistry, Genetics and Molecular Biology, Biotechnology, Complementary and Alternative Medicine, and Plant Science, the journal stands at the forefront of interdisciplinary research in medicinal plants. The Scopus rankings further enhance its reputation, highlighting its position as the leading journal in Complementary and Alternative Medicine and among the top resources in related fields. Spanning research from 2010 to 2024, it offers a valuable platform for disseminating innovative findings, thus playing an essential role in shaping future studies on ginseng and similar botanicals.

Discovery Medicine, an esteemed journal published by Discovery Medicine, serves as a vital platform within the field of general medicine, dedicated to advancing knowledge through high-quality research and innovative insights. With its ISSN 1539-6509 and E-ISSN 1944-7930, this journal boasts an impressive Scopus ranking of #29 out of 529 in the general medicine category, positioning it at the 94th percentile, indicating its significant contribution to the medical sciences. While operating as a subscription-based journal, Discovery Medicine fosters an environment where researchers and professionals can disseminate their findings and engage with cutting-edge developments in medicine. Spanning topics that bridge clinical practice and healthcare advancements, this journal aims to inform, challenge, and inspire the medical community. The journal has converged its volumes from 2006 to 2007 and again from 2009 to 2018, highlighting its sustained commitment to excellence even as coverage has temporarily discontinued in Scopus. Situated at 10 Gerard Ave, Ste 201, Timonium, MD 21093, Discovery Medicine continues to be a cornerstone for medical scholars, offering a rich repository of knowledge essential for ongoing research and practical applications.

Undersea and Hyperbaric Medicine is a pivotal journal published by the Undersea & Hyperbaric Medical Society Inc., focusing on the advanced field of undersea and hyperbaric medical research. It has served the scientific community since its inception in 1993, and is recognized for its commitment to disseminating peer-reviewed articles that address both the clinical and scientific aspects of hyperbaric medicine and related disciplines. The journal is indexed in various databases and classified in key quartiles, ranking Q3 in Medicine (miscellaneous) and Q4 in Physiology (medical) as of 2023, making it an essential resource for professionals engaged in these specialized areas. Although the journal does not currently offer open access, its implications and contributions to the fields of pulmonary and respiratory medicine and physiology are substantial, with a Scopus rank indicating its relevance despite some competitive challenges. This publication serves as a vital platform for researchers, allows for the exploration of novel therapies, and promotes the dissemination of knowledge critical for advancements in medical practice related to undersea and hyperbaric environments.

Physiology and Pharmacology is a distinguished open access journal that has been disseminating high-quality research in the fields of physiology and pharmacology since its inception in 1997. Published by the Iranian Society of Physiology & Pharmacology, this journal offers a platform for scholars and practitioners to share innovative findings and advancements that contribute to the understanding of biological systems and drug action. With its ISSN 2476-5236 and E-ISSN 2476-5244, it ensures global reach and accessibility. The journal is positioned in the third quartile for Linguistics and Language and fourth quartile in both Pharmacology and Physiology categories according to Scopus rankings, reflecting a commitment to expanding knowledge within these interdisciplinary domains. Set within the academic landscape of Iran, the journal aims to bridge regional research with the international community, providing valuable insights into physiological processes and pharmacological developments. In light of its open access model, the Physiology and Pharmacology journal plays a crucial role in enhancing the visibility of research outcomes and fostering collaboration among researchers, professionals, and students on a global scale.

The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.

Phytotherapy Research, a distinguished journal published by Wiley, stands at the forefront of the pharmacological literature, delivering essential insights into the therapeutic potential of plant-based interventions. With its ISSN 0951-418X and E-ISSN 1099-1573, the journal has firmly established itself since its inception in 1987, now converging into its 2024 volume. Notably positioned in the Q1 category of Pharmacology and ranked #22 out of 313 journals in the field, it boasts a remarkable 93rd percentile rating according to Scopus. While the journal adheres to subscription-based access, it remains a crucial repository of high-quality research findings that support the understanding and advancement of herbal medicines and phytotherapeutics. This journal serves as an invaluable resource for researchers, healthcare professionals, and students alike, fostering a deeper exploration of the synergistic relationship between nature and medicine and promoting evidence-based practices in the field.

ELECTROMAGNETIC BIOLOGY AND MEDICINE, published by Taylor & Francis Inc, is a pioneering journal that delves into the intricate relationships between electromagnetic fields and biological systems. With an ISSN of 1536-8378 and an E-ISSN of 1536-8386, this esteemed publication has been serving the scientific community since its inception in 1982. As a vital resource in the fields of biophysics and medical sciences, it is categorized in the Q3 quartile for both Biophysics and Medicine (miscellaneous) as of 2023, reflecting its significant contributions and robust research output. With Scopus rankings indicating a 61st percentile in Medicine and a 44th percentile in Biophysics, this journal is instrumental for researchers, professionals, and students seeking to explore the multifaceted applications of electromagnetic phenomena in health and medicine. This journal offers access options tailored to enhance visibility and dissemination of research, emphasizing its commitment to advancing knowledge and fostering innovation in this interdisciplinary domain.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, published by Taylor & Francis Ltd, has established itself as a premier forum for the dissemination of innovative research related to radiation biology, covering emerging topics that are crucial within the fields of radiology, nuclear medicine, and ultrasound technology. With an ISSN of 0955-3002 and an E-ISSN of 1362-3095, this journal spans over six decades, from its inception in 1959 to 2024, reflecting a rich history of scholarly contribution and a dynamic approach to addressing current challenges in the discipline. Its reputation is highlighted by its Q2 rankings in both Radiology, Nuclear Medicine and Imaging and Radiological and Ultrasound Technology for 2023, underscoring its relevance in a competitive academic landscape, with Scopus rankings placing it in the top tier of its category. While operating under a traditional access model, the journal aims to connect researchers, professionals, and students, facilitating the advancement of knowledge and fostering a deeper understanding of the impact of radiation in various medical applications. The journal plays an essential role in shaping future research directions and enhancing clinical practices globally.